{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:26:32Z","timestamp":1761765992532,"version":"build-2065373602"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.beem.2015.09.007","type":"journal-article","created":{"date-parts":[[2015,10,18]],"date-time":"2015-10-18T05:25:11Z","timestamp":1445145911000},"page":"115-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Somatic and germline mutations in NETs: Implications for their diagnosis and management"],"prefix":"10.1016","volume":"30","author":[{"given":"Marianna","family":"Minnetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2015.09.007_bib1","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.09.007_bib2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.beem.2015.09.007_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/humu.10092","article-title":"Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein","volume":"20","author":"Wautot","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1016\/j.beem.2015.09.007_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.beem.2015.09.007_bib5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ncpendmet0292","article-title":"Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation","volume":"2","author":"Dreijerink","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metabolism"},{"key":"10.1016\/j.beem.2015.09.007_bib6","doi-asserted-by":"crossref","first-page":"8397","DOI":"10.1158\/0008-5472.CAN-06-0061","article-title":"Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response","volume":"66","author":"Busygina","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2015.09.007_bib7","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1530\/ERC-13-0482","article-title":"Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis","volume":"21","author":"Pieterman","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2015.09.007_bib8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1572-0241.2007.01777.x","article-title":"Molecular genetics of gastroenteropancreatic neuroendocrine tumors","volume":"103","author":"Toumpanakis","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.beem.2015.09.007_bib9","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.09.007_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2015.09.007_bib11","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl. 3","key":"10.1016\/j.beem.2015.09.007_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4158\/EP10379.RA","article-title":"Role of multiple endocrine neoplasia type 1 mutational analysis in clinical practice","volume":"17","author":"Newey","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2015.09.007_bib13","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/jcmm.12552","article-title":"Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1","volume":"19","author":"Circelli","year":"2015","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.beem.2015.09.007_bib14","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/hmg\/ddt039","article-title":"Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study","volume":"22","author":"Thevenon","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2015.09.007_bib15","doi-asserted-by":"crossref","first-page":"E2387","DOI":"10.1210\/jc.2013-4432","article-title":"Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain","volume":"99","author":"Bartsch","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.09.007_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/EJE-10-0950","article-title":"Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines","volume":"165","author":"Goudet","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2015.09.007_bib17","first-page":"533","article-title":"Endocrine cancer syndromes: an update","volume":"66","author":"Anik","year":"2014","journal-title":"Minerva Pediatr"},{"issue":"Suppl. 3","key":"10.1016\/j.beem.2015.09.007_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4158\/EP10376.RA","article-title":"Pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: review of literature","volume":"17","author":"Tonelli","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2015.09.007_bib19","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.jamcollsurg.2007.06.320","article-title":"Role of surgery in Zollinger\u2013Ellison syndrome","volume":"205","author":"Norton","year":"2007","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.beem.2015.09.007_bib20","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJM199003153221103","article-title":"Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger\u2013Ellison syndrome","volume":"322","author":"Pipeleers-Marichal","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2015.09.007_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/cncr.20825","article-title":"Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1","volume":"103","author":"Sachithanandan","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2015.09.007_bib22","doi-asserted-by":"crossref","first-page":"E374","DOI":"10.1210\/jc.2013-2782","article-title":"MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoids","volume":"99","author":"Swarts","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.09.007_bib23","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2013-1204","article-title":"Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update","volume":"98","author":"Wells","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.09.007_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/j.seminoncol.2012.11.005","article-title":"The genetics of neuroendocrine tumors","volume":"40","author":"Oberg","year":"2013","journal-title":"Semin Oncol"},{"key":"10.1016\/j.beem.2015.09.007_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminoncol.2012.11.013","article-title":"The evolving landscape of neuroendocrine tumors","volume":"40","author":"Bergsland","year":"2013","journal-title":"Semin Oncol"},{"key":"10.1016\/j.beem.2015.09.007_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000346174","article-title":"2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer","volume":"1","author":"Elisei","year":"2013","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.beem.2015.09.007_bib27","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/MPA.0b013e3181ebb4f0","article-title":"The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer","volume":"39","author":"Chen","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.beem.2015.09.007_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/jhh.2012.20","article-title":"An update on the genetics of pheochromocytoma","volume":"27","author":"Karasek","year":"2013","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.beem.2015.09.007_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14310\/horm.2002.1218","article-title":"Genotype\u2013phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management","volume":"8","author":"Raue","year":"2009","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.beem.2015.09.007_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mce.2013.07.032","article-title":"Familial pheochromocytomas and paragangliomas","volume":"386","author":"King","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2015.09.007_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11102-006-0263-4","article-title":"RET and neuroendocrine tumors","volume":"9","author":"Murakumo","year":"2006","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2015.09.007_bib32","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jc.2007-1714","article-title":"Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study","volume":"93","author":"Elisei","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.09.007_bib33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1677\/erc.1.00683","article-title":"Von Hippel-Lindau disease and endocrine tumour susceptibility","volume":"13","author":"Woodward","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2015.09.007_bib34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","article-title":"von Hippel-Lindau disease: a clinical and scientific review","volume":"19","author":"Maher","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.beem.2015.09.007_bib35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5858\/arpa.2013-0520-RS","article-title":"Endocrine manifestations of von Hippel-Lindau disease","volume":"139","author":"Cassol","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.beem.2015.09.007_bib36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1677\/ERC-08-0239","article-title":"Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours","volume":"16","author":"Srirangalingam","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2015.09.007_bib37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/1066896914537683","article-title":"Hereditary pheochromocytoma","volume":"22","author":"Santos","year":"2014","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.beem.2015.09.007_bib38","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJM199906173402404","article-title":"Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2","volume":"340","author":"Eisenhofer","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2015.09.007_bib39","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jso.23157","article-title":"Hereditary pheochromocytoma and paraganglioma","volume":"106","author":"Mazzaglia","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.beem.2015.09.007_bib40","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/00365521.2014.992364","article-title":"Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center","volume":"50","author":"Park","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.beem.2015.09.007_bib41","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective","volume":"6","author":"Ferner","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.beem.2015.09.007_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1477-7819-10-153","article-title":"A\u00a0case of pancreatic neuroendocrine tumor in a patient with neurofibromatosis-1","volume":"10","author":"Nishi","year":"2012","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.beem.2015.09.007_bib43","first-page":"852","article-title":"Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen's disease): clinicopathological spectrum with pathogenetic considerations","volume":"5","author":"Agaimy","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.beem.2015.09.007_bib44","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/qjmed\/hcs203","article-title":"Neurofibromatosis type 1 and pancreatic islet cell tumours: an association which should be recognized","volume":"108","author":"Rogers","year":"2015","journal-title":"QJM"},{"key":"10.1016\/j.beem.2015.09.007_bib45","first-page":"297","article-title":"Neurofibromin in neurofibromatosis type 1-mutations in NF1gene as a cause of disease","volume":"18","author":"Abramowicz","year":"2014","journal-title":"Dev Period Med"},{"key":"10.1016\/j.beem.2015.09.007_bib46","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2015.09.007_bib47","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/1066896911428735","article-title":"Neuroendocrine tumor of the pancreas in a patient with tuberous sclerosis: a case report and review of the literature","volume":"20","author":"Diaz","year":"2012","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.beem.2015.09.007_bib48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/nyas.12122","article-title":"Development of everolimus, a novel oral mTOR inhibitor, across a spectrum of diseases","volume":"1291","author":"Lebwohl","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.beem.2015.09.007_bib49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1200\/JCO.2008.21.5988","article-title":"Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway","volume":"28","author":"Missiaglia","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beem.2015.09.007_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1677\/ERC-08-0142","article-title":"Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review","volume":"16","author":"Dworakowska","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2015.09.007_bib51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2796.2009.02110.x","article-title":"The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney\u2013Stratakis syndrome): molecular genetics and clinical implications","volume":"266","author":"Stratakis","year":"2009","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2015.09.007_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrendo.2014.188","article-title":"Paraganglioma and phaeochromocytoma: from genetics to personalized medicine","volume":"11","author":"Favier","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2015.09.007_bib53","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Castro-Vega","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2015.09.007_bib54","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJMoa1205119","article-title":"Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia","volume":"367","author":"Zhuang","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2015.09.007_bib55","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.2012.47.1912","article-title":"New syndrome of paraganglioma and somatostatinoma associated with polycythemia","volume":"31","author":"Pacak","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beem.2015.09.007_bib56","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1365-2826.2008.01755.x","article-title":"Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas","volume":"20","author":"Hrascan","year":"2008","journal-title":"J\u00a0Neuroendocrinol"},{"key":"10.1016\/j.beem.2015.09.007_bib57","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1210\/jc.2009-2170","article-title":"Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas","volume":"95","author":"Gaal","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.09.007_bib58","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-11-3891","article-title":"MAX and MYC: a heritable breakup","volume":"72","author":"Cascon","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2015.09.007_bib59","doi-asserted-by":"crossref","first-page":"E1352","DOI":"10.1210\/jc.2013-4375","article-title":"Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma","volume":"99","author":"Welander","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.09.007_bib60","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1210\/jc.2014-1659","article-title":"Germline FH mutations presenting with pheochromocytoma","volume":"99","author":"Clark","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl. 2","key":"10.1016\/j.beem.2015.09.007_bib61","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.33549\/physiolres.932789","article-title":"HIF signaling pathway in pheochromocytoma and other neuroendocrine tumors","volume":"63","author":"Jochmanova","year":"2014","journal-title":"Physiol Res"},{"key":"10.1016\/j.beem.2015.09.007_bib62","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/hmg\/ddt638","article-title":"The tumor susceptibility gene TMEM127 is mutated in renal cell carcinomas and modulates endolysosomal function","volume":"23","author":"Qin","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2015.09.007_bib63","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00109-014-1205-7","article-title":"Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma\/paraganglioma-polycythemia","volume":"93","author":"Yang","year":"2015","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.beem.2015.09.007_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djv053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","author":"Cascon","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.beem.2015.09.007_bib65","doi-asserted-by":"crossref","first-page":"E1376","DOI":"10.1210\/jc.2013-3879","article-title":"H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series","volume":"99","author":"Oudijk","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.09.007_bib66","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/cen.12530","article-title":"Testing for germline mutations in sporadic pheochromocytoma\/paraganglioma: a systematic review","volume":"82","author":"Brito","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2015.09.007_bib67","first-page":"1","article-title":"Rethinking pheochromocytomas and paragangliomas from a genomic perspective","author":"Castro-Vega","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.beem.2015.09.007_bib68","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.urology.2014.01.007","article-title":"The genetic basis of pheochromocytoma and paraganglioma: implications for management","volume":"83","author":"Shuch","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.beem.2015.09.007_bib69","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.mito.2010.03.001","article-title":"Succinate dehydrogenase \u2013 assembly, regulation and role in human disease","volume":"10","author":"Rutter","year":"2010","journal-title":"Mitochondrion"},{"key":"10.1016\/j.beem.2015.09.007_bib70","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma","volume":"19","author":"Burnichon","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2015.09.007_bib71","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.bbabio.2011.07.003","article-title":"SDH mutations in cancer","volume":"1807","author":"Bardella","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.beem.2015.09.007_bib72","first-page":"5615","article-title":"Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas","volume":"63","author":"Gimenez-Roqueplo","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2015.09.007_bib73","doi-asserted-by":"crossref","first-page":"E1482","DOI":"10.1210\/jc.2013-3853","article-title":"The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3)","volume":"99","author":"Else","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.09.007_bib74","first-page":"e273","article-title":"SDH-C mutations are associated with cardiac paragangliomas: a case report of a patient with a dopamine-secreting tumour and review of the literature","volume":"1","author":"Guelho","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2015.09.007_bib75","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1210\/jc.2007-0709","article-title":"Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas","volume":"92","author":"Amar","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.09.007_bib76","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1210\/jc.2013-3015","article-title":"Dandy\u2013Walker malformation, papillary thyroid carcinoma, and SDHD-associated paraganglioma syndrome","volume":"98","author":"Huguet","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.09.007_bib77","doi-asserted-by":"crossref","first-page":"E531","DOI":"10.1210\/jc.2014-3399","article-title":"Heterogeneous genetic background of the association of pheochromocytoma\/paraganglioma and pituitary adenoma: results from a large patient cohort","volume":"100","author":"Denes","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.09.007_bib78","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.beem.2015.09.007_bib79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2013.07.015","article-title":"Gastroenteropancreatic endocrine tumors","volume":"386","author":"Meeker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2015.09.007_bib80","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.1207313","article-title":"Altered telomeres in tumors with ATRX and DAXX mutations","volume":"333","author":"Heaphy","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.beem.2015.09.007_bib81","doi-asserted-by":"crossref","first-page":"L13","DOI":"10.1530\/ERC-15-0108","article-title":"Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours","volume":"22","author":"Pipinikas","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2015.09.007_bib82","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/j.gastro.2013.10.020","article-title":"Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors","volume":"146","author":"Marinoni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.beem.2015.09.007_bib83","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1677\/ERC-08-0297","article-title":"VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors","volume":"16","author":"Schmitt","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2015.09.007_bib84","doi-asserted-by":"crossref","first-page":"E766","DOI":"10.1210\/jc.2015-1100","article-title":"Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas","volume":"100","author":"Lichtenauer","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.09.007_bib85","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1038\/ncomms3810","article-title":"Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY","volume":"4","author":"Cao","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2015.09.007_bib86","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","article-title":"Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors","volume":"36","author":"Yachida","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beem.2015.09.007_bib87","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/ERC-12-0338","article-title":"Neuroendocrine tumours: cracking the epigenetic code","volume":"20","author":"Karpathakis","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2015.09.007_bib88","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/gcc.20561","article-title":"High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss","volume":"47","author":"Kulke","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beem.2015.09.007_bib89","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1677\/ERC-09-0052","article-title":"High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids","volume":"16","author":"Andersson","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2015.09.007_bib90","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1172\/JCI67963","article-title":"The genomic landscape of small intestine neuroendocrine tumors","volume":"123","author":"Banck","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2015.09.007_bib91","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2821","article-title":"Somatic mutation of CDKN1B in small intestine neuroendocrine tumors","volume":"45","author":"Francis","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2015.09.007_bib92","first-page":"1","article-title":"Somatic mutations and genetic Heterogeneity at the CDKN1B locus in small intestinal neuroendocrine tumors","author":"Crona","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.beem.2015.09.007_bib93","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/gcc.20834","article-title":"Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors","volume":"50","author":"Cunningham","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beem.2015.09.007_bib94","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.04.008","article-title":"A\u00a0hereditary form of small intestinal carcinoid associated with a germline mutation in inositol polyphosphate multikinase","author":"Sei","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.beem.2015.09.007_bib95","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/gcc.22183","article-title":"Tumor genetics and survival of thymic neuroendocrine neoplasms: a multi-institutional clinicopathologic study","volume":"53","author":"Strobel","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beem.2015.09.007_bib96","first-page":"255","article-title":"Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities","volume":"1826","author":"Swarts","year":"2012","journal-title":"Biochimica Biophys Acta"},{"key":"10.1016\/j.beem.2015.09.007_bib97","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1038\/ncomms4518","article-title":"Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids","volume":"5","author":"Fernandez-Cuesta","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2015.09.007_bib98","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.4103\/2230-8210.104058","article-title":"Multiple endocrine neoplasia type 1","volume":"16","author":"Thakker","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.09.007_bib99","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2265.2008.03324.x","article-title":"Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome","volume":"70","author":"Pieterman","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2015.09.007_bib100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2011.35.5040","article-title":"Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial","volume":"30","author":"Wells","year":"2012","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X15000962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X15000962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:50:56Z","timestamp":1761497456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X15000962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1521690X15000962"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2015.09.007","relation":{},"ISSN":["1521-690X"],"issn-type":[{"type":"print","value":"1521-690X"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatic and germline mutations in NETs: Implications for their diagnosis and management","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2015.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}